Chinese AI drug developer Deruizhiyao raises $52m
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
9/15
Depth
2/15
5-Axis Cultural Radar
The funding will also support phase III trials and commercialization of its oral glucagon-like peptide-1 (GLP-1) small-molecule drug candidate, MDR-001.
